多次单采成分献血者铁蛋白代谢及贫血相关指标水平变化研究

范恩勇, 孙海英, 戴超凡, 等. 多次单采成分献血者铁蛋白代谢及贫血相关指标水平变化研究[J]. 临床血液学杂志, 2022, 35(8): 552-555. doi: 10.13201/j.issn.1004-2806.2022.08.004
引用本文: 范恩勇, 孙海英, 戴超凡, 等. 多次单采成分献血者铁蛋白代谢及贫血相关指标水平变化研究[J]. 临床血液学杂志, 2022, 35(8): 552-555. doi: 10.13201/j.issn.1004-2806.2022.08.004
FAN Enyong, SUN Haiying, DAI Chaofan, et al. Study on changes of ferritin metabolism and anemia-related indexes in blood donors who donated platelets for many times[J]. J Clin Hematol, 2022, 35(8): 552-555. doi: 10.13201/j.issn.1004-2806.2022.08.004
Citation: FAN Enyong, SUN Haiying, DAI Chaofan, et al. Study on changes of ferritin metabolism and anemia-related indexes in blood donors who donated platelets for many times[J]. J Clin Hematol, 2022, 35(8): 552-555. doi: 10.13201/j.issn.1004-2806.2022.08.004

多次单采成分献血者铁蛋白代谢及贫血相关指标水平变化研究

  • 基金项目:
    江苏省输血协会英科新创科研基金项目(No:JS20190032)
详细信息

Study on changes of ferritin metabolism and anemia-related indexes in blood donors who donated platelets for many times

More Information
  • 目的 了解多次单采成分血献血者铁蛋白代谢及贫血相关指标变化情况。方法 按照是否多次捐献单采成分血进行分组,试验组:多次单采成分血献血者150例; 对照组:以往无献血史,首次来血站进行献血者150例。为了解各相关指标与年龄的相关性,将每组再按性别分成18~35岁,36~45岁,46~60岁3个年龄段。利用全自动血球分析仪对抗凝标本进行红细胞(RBC)、血红蛋白(Hb)、血细胞比容(HCT)、平均红细胞体积(MCV)、红细胞分布宽度(RDW)等血细胞指标检测; 利用全自动生化分析仪对促凝标本进行铁蛋白(FER)、叶酸和维生素B12(VitB12)等项目检测。结果 试验组男性RBC、Hb、叶酸较对照组升高,FER、VitB12水平降低,差异均有统计学意义(P< 0.05);试验组女性FER较对照组降低(P< 0.05),36~45岁水平最低,在46~60岁时有明显回升。男性VitB12水平总体有所降低,女性总体有所升高,在46~60岁男性与女性均较其他年龄段明显降低,差异有统计学意义(P< 0.05)。多次单采成分组FER、叶酸和VitB12水平于献血当天水平最低,后期逐渐回升,28 d基本恢复到献血前水平。结论 建议对育龄和绝经前的妇女及46~60岁等多次献血人群定期监测铁蛋白代谢及贫血相关指标,确保成分献血者身体健康和献血安全。
  • 加载中
  • 表 1  300例无偿献血者相关指标检测情况 X±S

    组别 性别 年龄/岁 例数 平均献血次数 RBC/(×1012·L-1) Hb/(g·L-1) HCT/% MCV/fl RDW/% FER/(ng·mL-1) 叶酸/(nmol·L-1) VitB12/(pmol·L-1)
    试验组 39.7 83 29.9 5.43±0.46 166±13 49.1±3.5 83.2±3.4 11.4±0.5 88.9±60.1 17.7±16.5 286±134
    18~35 26 12.0 5.48±0.39 168±10 49.5±3.1 83.1±2.9 11.3±0.4 84.7±69.2 19.8±28.4 281±132
    36~45 28 33.9 5.38±0.45 166±15 49.0±3.8 83.9±3.8 11.2±0.5 90.0±51.4 15.8±5.9 316±167
    46~60 29 42.5 5.44±0.54 164±17 48.8±4.5 82.7±3.1 11.6±0.5 85.6±56.8 19.0±8.1 253± 92
    41.5 67 20.9 4.57±0.27 139±9 41.5±2.2 83.4±2.6 11.2±0.5 37.1±28.3 22.1±7.0 396±166
    18~35 28 18.9 4.60±0.22 142±7 41.8±1.7 83.4±4.1 11.0±0.3 45.4±33.3 19.7±7.5 435±229
    36~45 16 17.0 4.63±0.38 139±15 41.5±3.4 82.5±2.3 11.2±0.5 20.8±12.2 23.7±7.5 428±27
    46~60 23 26.0 4.51±0.26 137±7 41.2±2.1 83.9±1.3 11.3±0.7 43.6±24.1 23.7±6.5 318±118
    对照组 39.3 85 0 5.29±0.47 162±12 48.5±3.5 84.3±3.3 11.3±0.5 257.4±173.1 15.0±6.5 325±151
    18~35 40 0 5.34±0.56 162±16 48.4±4.5 83.4±3.3 11.4±0.6 324.4±197.9 10.9±3.7 344±66
    36~45 17 0 5.22±0.51 160±13 47.9±3.6 84.6±3.8 11.3±0.5 217.8±228.9 12.2±3.0 271±37
    46~55 28 0 5.25±0.56 161±14 48.0±4.2 84.2±3.3 11.2±0.3 187.5±69.1 22.5±4.3 332±265
    39.0 65 0 4.47±0.30 136±8 41.6±2.7 85.4±2.8 11.3±0.7 65.1±59.4 17.9±6.3 363±112
    18~35 30 0 4.56±0.45 138±12 42.1±3.5 85.0±3.7 11.6±0.6 76.8±58.7 13.5±3.1 366±115
    36~45 13 0 4.44±0.24 137±8 41.8±2.6 86.6±2.2 10.8±0.3 29.6±44.8 16.5±2.9 337±133
    46~55 22 0 4.35±0.31 136±10 40.7±3.5 85.3±4.0 11.5±0.6 70.0±70.4 25.0±4.7 376±121
    正常参考值 男女 4.3~5.83.8~5.1 130~175115~150 40.0~50.035.0~45.0 80~94 10~16 21.8~274.74.6~204.0 7.0~46.4 138~652
    下载: 导出CSV

    表 2  60例多次单采成分献血者FER、叶酸、VitB12水平跟踪调查情况 X±S

    时间 项目 18~35岁 36~45岁 46~60岁
    男(10例) 女(10例) 男(10例) 女(10例) 男(10例) 女(10例)
    献血前 FER/(ng·mL-1) 84.5±56.5 45.1±21.4 88.5±40.3.4 20.2±10.7 86.1±39.8 43.3±21.5
    叶酸/(nmol·L-1) 19.5±19.3 19.3±6.2 14.9±5.5 23.0±7.1 19.0±7.5 23.5±6.5
    VitB12/(pmol·L-1) 278±110 430±192 307±132 419±127 253±89 320±106
    献血后0 d
    FER/(ng·mL-1) 74.1±58.5 38.6±25.2 76.6±44.5 17.7±9.9 74.4±48.8 37.5±19.4
    叶酸/(nmol·L-1) 16.0±24.2 15.5±9.2 13.4±4.3 20.5±6.8 16.5±7.3 20.1±6.1
    VitB12/(pmol·L-1) 244±113 367±192 274±145 366±113 222±79 269±101
    献血后14 d
    FER/(ng·mL-1) 79.9±60.2 19.5±29.6 83.3±47.7 19.3±10.5 79.9±52.5 40.3±21.2
    叶酸/(nmol·L-1) 18.4±22.4 17.8±10.3 14.7±4.8 22.1±7.0 17.8±7.7 22.0±6.3
    VitB12/(pmol·L-1) 266±125 396±211 292±152 394±98 236±84 294±111
    献血后28 d
    FER/(ng·mL-1) 84.1±53.3 45.4±19.8 90.0±42.5 20.5±10.9 85.6±42.4 43.6±19.8
    叶酸/(nmol·L-1) 19.1±18.6 19.6±7.0 15.1±5.8 23.7±7.5 19.4±7.9 23.7±6.6
    VitB12/(pmol·L-1) 281±104 435±189 301±122 428±112 262±99 325±108
    下载: 导出CSV
  • [1]

    Ji Y, Flower R, Hyland C, et al. Genetic factors associated with iron storage in Australian blood donors[J]. Blood Transfus, 2018, 16(2): 123-129.

    [2]

    Lobier M, Niittymäki P, Nikiforow N, et al. FinDonor 10 000 study: a cohort to identify iron depletion and factors affecting it in Finnish blood donors[J]. Vox Sang, 2020, 115(1): 36-46. doi: 10.1111/vox.12856

    [3]

    Kaptoge S, Di Angelantonio E, Moore C, et al. Longer-term efficiency and safety of increasing the frequency of whole blood donation(INTERVAL): extension study of a randomised trial of 20 757 blood donors[J]. Lancet Haematol, 2019, 6(10): e510-e520. doi: 10.1016/S2352-3026(19)30106-1

    [4]

    卢瑞, 张梦潇, 张爱边, 等. 红细胞分布宽度对原发性血小板增多症和真性红细胞增多症患者血栓形成及其预后的预测价值[J]. 临床血液学杂志, 2021, 34(11): 785-789. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXZ202111008.htm

    [5]

    Lobier M, Castrén J, Niittymäki P, et al. The effect of donation activity dwarfs the effect of lifestyle, diet and targeted iron supplementation on blood donor iron stores[J]. PLoS One, 2019, 14(8): e0220862. doi: 10.1371/journal.pone.0220862

    [6]

    Spencer BR, Bialkowski W, Creel DV, et al. Elevated risk for iron depletion in high-school age blood donors[J]. Transfusion, 2019, 59(5): 1706-1716. doi: 10.1111/trf.15133

    [7]

    Patel EU, White JL, Bloch EM, et al. Association of blood donation with iron deficiency among adolescent and adult females in the United States: a nationally representative study[J]. Transfusion, 2019, 59(5): 1723-1733. doi: 10.1111/trf.15179

    [8]

    邵雷, 王金花, 林红. 江苏地区全血献血者铁代谢相关基因多态性与铁储备水平的相关性分析[J]. 临床血液学杂志, 2020, 33(8): 557-562. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXZ202008011.htm

    [9]

    Vhanda D, Chinowaita F, Nkomo S, et al. Effects of repeated blood donation on iron status of blood donors in Zimbabwe: A cross-sectional study[J]. Health Sci Rep, 2021, 4(4): e426.

    [10]

    Spencer BR, Guo Y, Cable RG, et al. Iron status and risk factors for iron depletion in a racially/ethnically diverse blood donor population[J]. Transfusion, 2019, 59(10): 3146-3156. doi: 10.1111/trf.15448

    [11]

    Timmer TC, de Groot R, Rijnhart J, et al. Dietary intake of heme iron is associated with ferritin and hemoglobin levels in Dutch blood donors: results from Donor InSight[J]. Haematologica, 2020, 105(10): 2400-2406.

    [12]

    戚艳萍, 何博, 黄晓斌, 等. 不同间隔期、献血量对献血者血清铁和铁蛋白影响效果观察[J]. 中国输血杂志, 2019, 32(6): 570-572. https://www.cnki.com.cn/Article/CJFDTOTAL-BLOO201906019.htm

    [13]

    丁培燕. 定期无偿献血对血清铁及其铁蛋白的影响[J]. 医疗装备, 2018, 31(16): 48-48. https://www.cnki.com.cn/Article/CJFDTOTAL-YLZB201816032.htm

    [14]

    Wang HH, Liao LN, Chang CW, et al. The alteration of ferritin and transferrin saturation under body mass index and blood pressure in first-time and regular male blood donors in Taiwan[J]. Medicine(Baltimore), 2019, 98(22): e15854.

    [15]

    赵会霞, 焦淑贤, 杨忠思, 等. 45岁以上固定大量献血者铁蛋白及血红蛋白水平调查[J]. 临床血液学杂志, 2018, 31(8): 576-579. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXZ201808002.htm

    [16]

    Spekman M, Ramondt S, Sweegers MG. Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy[J]. Transfusion, 2021, 61(4): 1112-1121.

    [17]

    Mast AE, Langer JC, Guo Y, et al. Genetic and behavioral modification of hemoglobin and iron status among first-time and high-intensity blood donors[J]. Transfusion, 2020, 60(4): 747-758.

  • 加载中

(2)

计量
  • 文章访问数:  1032
  • PDF下载数:  457
  • 施引文献:  0
出版历程
收稿日期:  2021-12-27
修回日期:  2022-01-29
刊出日期:  2022-08-01

目录